Our Services
Medical Information
Helpful Resources
Published on: 5/22/2026
Finding a clinical trial for treatment-resistant chronic hives involves confirming your diagnosis and treatment history, consulting a specialist, and searching reputable registries for studies that suit your needs.
You’ll then review eligibility criteria, contact trial sites with key questions, weigh risks and benefits, prepare for screening visits, and plan for post-trial care. See below for all the important details and considerations that could impact your next steps.
Living with chronic hives (also known as chronic urticaria) that don't respond to standard treatments can be frustrating. Clinical trials offer access to cutting-edge therapies and expert care teams. This guide walks you through the process of finding a trial that may suit your needs, using reliable resources and practical steps.
Before seeking a clinical trial, make sure your chronic hives diagnosis and treatment history are up to date:
Accurate records help you and trial coordinators determine eligibility and safety.
Clinical trials often require a referral or letter of medical necessity:
Your doctor's support can smooth the enrollment process and ensure continuity of care.
Several trusted registries list active clinical trials. While you won't link directly to them here, you can access these by entering their names in your web browser:
When searching, use keywords such as:
Pay attention to:
Each trial has specific requirements. Common criteria include:
Create a checklist to compare your medical history against each trial's criteria. If you're uncertain, reach out to the trial coordinator with your questions.
Once you've identified a promising trial, reach out by phone or email. Good questions to ask include:
Taking notes during these conversations helps you compare options and make an informed choice.
Enrolling in a clinical trial involves potential benefits and drawbacks:
Potential Benefits
Potential Risks
Discuss these factors with your family, support network, and healthcare providers.
If you decide to proceed, the trial site will schedule a screening visit to confirm your eligibility. To prepare:
Screening visits may last several hours and include blood draws, physical exams, and questionnaires.
Managing trial participation alongside daily life can be challenging. Use these tips:
Consistent communication with the research team ensures you stay on track and report any concerns promptly.
Throughout the trial, you'll likely track your hives and related symptoms. Regular monitoring helps both you and the research team:
Before approaching a trial, you can use a free AI-powered Chronic Urticaria symptom checker to better understand your condition, identify patterns in your symptoms, and prepare informed questions to share with your care team and trial coordinators.
Clinical trials have defined durations. Before you enroll, ask about:
Knowing what happens next helps you maintain continuity of care and make future treatment decisions.
Patient advocacy groups can offer support, education, and updates on new trials:
These organizations often provide newsletters, webinars, and community connections.
Finding and enrolling in a clinical trial takes time, research, and collaboration with your healthcare team. Trials can offer hope when standard treatments fail, but they also require careful consideration of risks, benefits, and practical details.
Remember to:
Your proactive steps today could lead to better treatments—and a brighter tomorrow—for yourself and others living with treatment-resistant chronic hives.
(References)
* Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Aygören-Pürsün E, Bindslev-Jensen C, Brockow K, Caballero T, Camgoz B, Cardona V, D'Amato G, Dawson L, Fomina D, Ghazanfar MN, Giménez-Arnau AM, Grattan C, Hide M, Hötzenecker W, Ishii N, Jochmann A, Kambe N, Kaplan AP, Kocatürk E, Kolkhir P, Kothari A, K Sterling K, Magerl M, Makris M, Maurer M, Mustafa S, Nakazawa K, Niedoszytko M, Ohsawa I, Ortac C, Paulino M, Peter J, Pfaar O, Radonjic-Häkli E, Reich A, Reichrath J, Rodríguez-González M, Ruëff F, Saini SS, Salek G, Sánchez-Borges M, Schäfer G, Schmid-Grendelmeier P, Sheikh A, Sindrilaru A, Stelzle J, Thomsen SF, Vadas P, Vestergaard C, Vlahopoulos S, Vonakis I, Wagner N, Wemeau AC, Wedi B, Xepapadaki P, Zampeli V, Zuberbier T. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022 Mar;77(3):825-866. doi: 10.1111/all.15090. Epub 2021 Nov 16. PMID: 34791689.
* Maurya A, Arora T, Singh BP, Rawat S, Kumar V, Singh P, Vasanthapuram R, Saini SS, Sarin S. Management of Chronic Spontaneous Urticaria Refractory to Standard Therapies: Beyond Antihistamines. J Allergy Clin Immunol Pract. 2022 Jul;10(7):1748-1756. doi: 10.1016/j.jacip.2022.04.030. Epub 2022 May 3. PMID: 35523554.
* Kolkhir P, Altrichter S, Hawro T, Skov PS, Zuberbier T, Maurer M. Emerging Therapeutic Options for Chronic Spontaneous Urticaria. Drugs. 2022 May;82(7):737-759. doi: 10.1007/s40265-022-01708-3. Epub 2022 Apr 20. PMID: 35441315.
* Saini SS. Chronic Spontaneous Urticaria: Pathogenesis, Diagnosis, and Treatment. Allergy Asthma Proc. 2022 Mar 22;43(2):107-113. doi: 10.2500/aap.2022.43.210086. PMID: 35308873.
* Weller K, Zuberbier T. Unmet needs in chronic spontaneous urticaria: Future directions. Clin Rev Allergy Immunol. 2019 Jun;56(3):362-371. doi: 10.1007/s12016-018-8725-3. PMID: 30467773.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.